FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 326:600-604 February 27, 1992 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND AND METHODS. The effect of delayed puberty on peak bone mineral density in men is unknown. To determine whether such a delay reduces normal peak bone density and leads to osteopenia during adulthood, we measured radial bone mineral density by single-photon absorptiometry and spinal bone mineral density by dual-energy x-ray absorptiometry in 23 men who had a history of constitutionally delayed puberty and 21 men who underwent normal puberty. Their mean ages were 26 and 24 years, respectively. The groups were matched for other factors known to affect bone mass. RESULTS. The mean (+/- SD) radial bone mineral density was significantly lower in the men with a history of delayed puberty than in the normal men (0.73 +/- 0.07 vs. 0.80 +/- 0.05 g per square centimeter; P less than 0.0002). Spinal bone mineral density was also significantly lower in the men with delayed puberty than in the normal men (1.03 +/- 0.10 vs. 1.13 +/- 0.11 g per square centimeter; P less than 0.003). Radial bone density was at least 1 SD below the mean value for the normal men in 15 of the 23 men with a history of delayed puberty, and spinal bone density was similarly decreased in 10 of the 23. CONCLUSIONS. Adult men with a history of constitutionally delayed puberty have decreased radial and spinal bone mineral density. These findings suggest that the timing of puberty is an important determinant of peak bone density in men. Because the peak bone mineral density achieved during young adulthood is a major determinant of bone density in later life, men in whom puberty was delayed may be at increased risk for osteoporotic fractures when they are older.

Source Information

Department of Medicine, Massachusetts General Hospital, Boston 02114.

This article has been cited by other articles:

• Sylvester, F. A. (2009). Effects of Inflammatory Bowel Diseases on Bone Metabolism. IBMS BoneKEy 6: 420-428 [Abstract] [Full Text]  
• Fernandez, A., Brada, M., Zabuliene, L., Karavitaki, N., Wass, J. A H (2009). Radiation-induced hypopituitarism. Endocr Relat Cancer 16: 733-772 [Abstract] [Full Text]  
• Mohamed, I., Yeh, J. K (2009). Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats. J Endocrinol 202: 317-325 [Abstract] [Full Text]  
• Giustina, A., Mazziotti, G., Canalis, E. (2008). Growth Hormone, Insulin-Like Growth Factors, and the Skeleton. Endocr. Rev. 29: 535-559 [Abstract] [Full Text]  
• van Gool, S. A., Kamp, G. A., Visser-van Balen, H., Mul, D., Waelkens, J. J. J., Jansen, M., Verhoeven-Wind, L., Delemarre-van de Waal, H. A., de Muinck Keizer-Schrama, S. M. P. F., Leusink, G., Roos, J. C., Wit, J. M. (2007). Final Height Outcome after Three Years of Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Short Adolescents with Relatively Early Puberty. J. Clin. Endocrinol. Metab. 92: 1402-1408 [Abstract] [Full Text]  
• Bonjour, J.-P., Chevalley, T. (2007). Pubertal Timing, Peak Bone Mass and Fragility Fracture Risk. IBMS BoneKEy 4: 30-48 [Abstract] [Full Text]  
• Han, J. C., Balagopal, P., Sweeten, S., Darmaun, D., Mauras, N. (2006). Evidence for Hypermetabolism in Boys with Constitutional Delay of Growth and Maturation. J. Clin. Endocrinol. Metab. 91: 2081-2086 [Abstract] [Full Text]  
• Fujita, T., Ohtani, J., Shigekawa, M., Kawata, T., Kaku, M., Kohno, S., Motokawa, M., Tohma, Y., Tanne, K. (2006). Influence of sex hormone disturbances on the internal structure of the mandible in newborn mice. Eur J Orthod 28: 190-194 [Abstract] [Full Text]  
• Rochira, V, Balestrieri, A, Madeo, B, Zirilli, L, Granata, A R M, Carani, C (2006). Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. Eur J Endocrinol 154: 175-185 [Abstract] [Full Text]  
• Buison, A. M., Kawchak, D. A., Schall, J. I., Ohene-Frempong, K., Stallings, V. A., Leonard, M. B., Zemel, B. S. (2005). Bone Area and Bone Mineral Content Deficits in Children With Sickle Cell Disease. Pediatrics 116: 943-949 [Abstract] [Full Text]  
• Arabi, A., Tamim, H., Nabulsi, M., Maalouf, J., Khalife, H., Choucair, M., Vieth, R., El-Hajj Fuleihan, G. (2004). Sex differences in the effect of body-composition variables on bone mass in healthy children and adolescents. Am. J. Clin. Nutr. 80: 1428-1435 [Abstract] [Full Text]  
• Yap, F., Hogler, W., Briody, J., Moore, B., Howman-Giles, R., Cowell, C. T. (2004). The Skeletal Phenotype of Men with Previous Constitutional Delay of Puberty. J. Clin. Endocrinol. Metab. 89: 4306-4311 [Abstract] [Full Text]  
• Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., Ohlsson, C. (2004). Androgens and Bone. Endocr. Rev. 25: 389-425 [Abstract] [Full Text]  
• Wickman, S., Kajantie, E., Dunkel, L. (2003). Effects of Suppression of Estrogen Action by the P450 Aromatase Inhibitor Letrozole on Bone Mineral Density and Bone Turnover in Pubertal Boys. J. Clin. Endocrinol. Metab. 88: 3785-3793 [Abstract] [Full Text]  
• Mahachoklertwattana, P., Sirikulchayanonta, V., Chuansumrit, A., Karnsombat, P., Choubtum, L., Sriphrapradang, A., Domrongkitchaiporn, S., Sirisriro, R., Rajatanavin, R. (2003). Bone Histomorphometry in Children and Adolescents with {beta}-Thalassemia Disease: Iron-Associated Focal Osteomalacia. J. Clin. Endocrinol. Metab. 88: 3966-3972 [Abstract] [Full Text]  
• Taback, S. P., Sellers, E. A.C., Dean, H. J., Lee, M. M. (2003). Is Luteinizing Hormone-Releasing Hormone Agonist Justified in Short Adolescents?. NEJM 349: 192-193 [Full Text]  
• Yanovski, J. A., Rose, S. R., Municchi, G., Pescovitz, O. H., Hill, S. C., Cassorla, F. G., Cutler, G. B. Jr. (2003). Treatment with a Luteinizing Hormone-Releasing Hormone Agonist in Adolescents with Short Stature. NEJM 348: 908-917 [Abstract] [Full Text]  
• Seeman, E. (2001). Sexual Dimorphism in Skeletal Size, Density, and Strength. J. Clin. Endocrinol. Metab. 86: 4576-4584 [Full Text]  
• Ankarberg-Lindgren, C., Elfving, M., Wikland, K. A., Norjavaara, E. (2001). Nocturnal Application of Transdermal Estradiol Patches Produces Levels of Estradiol That Mimic Those Seen at the Onset of Spontaneous Puberty in Girls. J. Clin. Endocrinol. Metab. 86: 3039-3044 [Abstract] [Full Text]  
• Prelevic, G. M (2001). Osteoporosis in men. JRSM 94: 620-623 [Full Text]  
• Compston, J. E. (2001). Sex Steroids and Bone. Physiol. Rev. 81: 419-447 [Abstract] [Full Text]  
• Soyka, L. A., Fairfield, W. P., Klibanski, A. (2000). Hormonal Determinants and Disorders of Peak Bone Mass in Children. J. Clin. Endocrinol. Metab. 85: 3951-3963 [Full Text]  
• Katz, M. S. (2000). Geriatrics Grand Rounds: Eve's Rib, or a Revisionist View of Osteoporosis in Men. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 55: 560M-569 [Abstract] [Full Text]  
• Rakover, Y., Lu, P., Briody, J. N., Tao, C., Weiner, E., Ederveen, A. G.H., Cowell, C. T., Ben-Shlomo, I. (2000). Effects of delaying puberty on bone mineralization in female rats. Hum Reprod 15: 1457-1461 [Abstract] [Full Text]  
• Thearle, M., Horlick, M., Bilezikian, J. P., Levy, J., Gertner, J. M., Levine, L. S., Harbison, M., Berdon, W., Oberfield, S. E. (2000). Osteoporosis: An Unusual Presentation of Childhood Crohn's Disease. J. Clin. Endocrinol. Metab. 85: 2122-2126 [Abstract] [Full Text]  
• Rochira, V., Faustini-Fustini, M., Balestrieri, A., Carani, C. (2000). Estrogen Replacement Therapy in a Man with Congenital Aromatase Deficiency: Effects of Different Doses of Transdermal Estradiol on Bone Mineral Density and Hormonal Parameters. J. Clin. Endocrinol. Metab. 85: 1841-1845 [Abstract] [Full Text]  
• (1999). Estrogen Receptor Gene Polymorphism, But Not Estradiol Levels, Is Related to Bone Density in Healthy Adolescent Boys: A Cross-Sectional and Longitudinal Study. J. Clin. Endocrinol. Metab. 84: 4597-4601 [Abstract] [Full Text]  
• Beishuizen, A., Vermes, I. (1999). Relative Eosinophilia (Thorn Test) as a Bioassay to Judge the Clinical Relevance of Cortisol Values during Severe Stress. J. Clin. Endocrinol. Metab. 84: 3400-3401 [Full Text]  
• Bertelloni, S., Baroncelli, G. I., Saggese, G. (1999). Normal Volumetric Bone Mineral Density in Young Men with Histories of Constitutional Delay of Puberty--Authors' Response. J. Clin. Endocrinol. Metab. 84: 3403-3404 [Full Text]  
• Finkelstein, J. S., Klibanski, A., Neer, R. M. (1999). Comment on Normal Volumetric Bone Mineral Density and Bone Turnover in Young Men with Histories of Constitutional Delay of Puberty. J. Clin. Endocrinol. Metab. 84: 3400a-3402 [Full Text]  
• Bertelloni, S., Baroncelli, G. I., Ferdeghini, M., Perri, G., Saggese, G. (1998). Normal Volumetric Bone Mineral Density and Bone Turnover in Young Men with Histories of Constitutional Delay of Puberty. J. Clin. Endocrinol. Metab. 83: 4280-4283 [Abstract] [Full Text]  
• Finkelstein, J. S., Klibanski, A., Arnold, A. L., Toth, T. L., Hornstein, M. D., Neer, R. M. (1998). Prevention of Estrogen Deficiency-Related Bone Loss With Human Parathyroid Hormone-(1-34): A Randomized Controlled Trial. JAMA 280: 1067-1073 [Abstract] [Full Text]  
• Bilezikian, J. P., Morishima, A., Bell, J., Grumbach, M. M. (1998). Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency. NEJM 339: 599-603 [Full Text]  
• Ohlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., Slootweg, M. C. (1998). Growth Hormone and Bone. Endocr. Rev. 19: 55-79 [Abstract] [Full Text]  
• Boot, A M, Bouquet, J, Krenning, E P, de Muinck Keizer-Schrama, S M P F (1998). Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 42: 188-194 [Abstract] [Full Text]  
• Vanderschueren, D., Van Herck, E., Nijs, J., Ederveen, A. G. H., De Coster, R., Bouillon, R. (1997). Aromatase Inhibition Impairs Skeletal Modeling and Decreases Bone Mineral Density in Growing Male Rats. Endocrinology 138: 2301-2307 [Abstract] [Full Text]  
• JÄRVINEN, M., KANNUS, P. (1997). Current Concepts Review - Injury of an Extremity as a Risk Factor for the Development of Osteoporosis. JBJS 79: 263-76 [Full Text]  
• Finkelstein, J. S., Klibanski, A., Schaefer, E. H., Hornstein, M. D., Schiff, I., Neer, R. M. (1994). Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency. NEJM 331: 1618-1623 [Abstract] [Full Text]  
• Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., Korach, K. S. (1994). Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man. NEJM 331: 1056-1061 [Abstract] [Full Text]